These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33800788)

  • 1. Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration.
    Sabir F; Katona G; Pallagi E; Dobó DG; Akel H; Berkesi D; Kónya Z; Csóka I
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
    Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
    Tiantian Y; Wenji Z; Mingshuang S; Rui Y; Shuangshuang S; Yuling M; Jianhua Y; Xinggang Y; Shujun W; Weisan P
    Int J Pharm; 2014 Aug; 471(1-2):245-57. PubMed ID: 24858386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal and follicular delivery of adapalene liposomes.
    Kumar V; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach.
    Soni PK; Saini TR
    Drug Dev Ind Pharm; 2021 Nov; 47(11):1847-1866. PubMed ID: 35484943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Characterization of
    Sabir F; Katona G; Ismail R; Sipos B; Ambrus R; Csóka I
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Lomustine and
    Katona G; Sabir F; Sipos B; Naveed M; Schelz Z; Zupkó I; Csóka I
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
    Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
    Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer.
    Negi LM; Jaggi M; Joshi V; Ronodip K; Talegaonkar S
    Int J Biol Macromol; 2015 Feb; 73():222-35. PubMed ID: 25478964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia.
    Salade L; Wauthoz N; Deleu M; Vermeersch M; De Vriese C; Amighi K; Goole J
    Int J Nanomedicine; 2017; 12():8531-8543. PubMed ID: 29238190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid-functionalized bilosomes for targeted delivery of tripterine to inflamed area with enhancive therapy on arthritis.
    Yang H; Liu Z; Song Y; Hu C
    Drug Deliv; 2019 Dec; 26(1):820-830. PubMed ID: 31389248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
    Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
    Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical study of Doxorubicine-loaded liposomal drug delivery for the treatment of head and neck cancer: Optimization by Box-Behnken statistical design.
    Yang B
    Acta Biochim Pol; 2020 Jun; 67(2):149-155. PubMed ID: 32506868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of risperidone liposomes for brain targeting through intranasal route.
    Narayan R; Singh M; Ranjan O; Nayak Y; Garg S; Shavi GV; Nayak UY
    Life Sci; 2016 Oct; 163():38-45. PubMed ID: 27593571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters.
    Cunha S; Costa CP; Loureiro JA; Alves J; Peixoto AF; Forbes B; Sousa Lobo JM; Silva AC
    Pharmaceutics; 2020 Jun; 12(7):. PubMed ID: 32605177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal hydrogel formulation for transdermal delivery of pirfenidone.
    Jose A; Mandapalli PK; Venuganti VV
    J Liposome Res; 2016; 26(2):139-47. PubMed ID: 26114208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.